PetMed Express (NASDAQ: PETS) reported Q3 EPS of $0.24, $0.01 worse than the analyst estimate of $0.25. Revenue for the quarter came in at $50.9 million versus the consensus estimate of $49.28 million.

The increase in sales for the quarter ended December 31, 2015 can be attributed to increased new order sales, which increased 6.8%, and reorders sales, which increased 2.8%.

For earnings history and earnings-related data on PetMed Express (PETS) click here.